Although federal prosecutors abruptly abandoned a criminal investigation related to doping accusations against Lance Armstrong earlier this year, the report released on Wednesday by antidoping officials is likely to create new legal issues for Armstrong.

The United States Anti-Doping agency’s report, which amounted to a damning depiction of Armstrong as a main conspirator in a vast doping scheme, contended that Armstrong repeatedly lied under oath. That element of the report is sure to revive attempts by an insurer to recoup a $5 million performance bonus it covered after Armstrong won the Tour de France in 2004.

After promising Armstrong a bonus, his United States Postal Service team protected itself against that potential financial liability through a policy from SCA Promotions, a company based in Dallas that specializes in assuming risks associated with prizes. Because a French book detailed allegations of doping against Armstrong in 2004, SCA initially balked at paying. After a protracted arbitration process, the insurer ultimately agreed to settle for $7.5 million in 2006. The additional $2.5 million covered interest as well as Armstrong’s legal costs.

The antidoping agency said it found Armstrong committed perjury during the SCA hearings by making false statements about his doping activities. At the time, Armstrong attacked SCA and its founder, Bob Hamman, as well as witnesses, including some members of the cycling community, who testified for the company.